COOP vs. KRYS

Last updated Apr 2, 2026

Compare and contrast key facts about Mr. Cooper Group Inc. (COOP) and Krystal Biotech, Inc. (KRYS).

Performance

COOP vs. KRYS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Mr. Cooper Group Inc. (COOP) and Krystal Biotech, Inc. (KRYS). The values are adjusted to include any dividend payments, if applicable.

COOP vs. KRYS - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
COOP Mr. Cooper Group Inc.	0.00%	121.64%	47.44%	62.27%	-3.56%	34.10%	148.04%	7.20%	14.53%	-22.81%
KRYS Krystal Biotech, Inc.	5.02%	57.37%	26.28%	56.60%	13.25%	16.58%	8.34%	166.51%	97.53%	-1.13%

Fundamentals

Market Cap COOP : $13.72B KRYS : $7.75B
EPS COOP : $8.76 KRYS : $6.86
PE Ratio COOP : 24.07 KRYS : 37.72
PEG Ratio COOP : 0.24 KRYS : 0.09
PS Ratio COOP : 6.00 KRYS : 19.86
PB Ratio COOP : 2.69 KRYS : 6.36
Total Revenue (TTM) COOP : $2.29B KRYS : $389.13M
Gross Profit (TTM) COOP : $1.68B KRYS : $0.00
EBITDA (TTM) COOP : $852.00M KRYS : $161.30M

Returns By Period

COOP

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

KRYS

• 1D: 0.23%
• 1M: 0.04%
• YTD: 5.02%
• 6M: 44.15%
• 1Y: 48.30%
• 3Y*: 47.88%
• 5Y*: 27.54%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

COOP vs. KRYS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

KRYS

KRYS Risk / Return Rank: 70
KRYS Sharpe Ratio Rank: 77
KRYS Sortino Ratio Rank: 69
KRYS Omega Ratio Rank: 70
KRYS Calmar Ratio Rank: 68
KRYS Martin Ratio Rank: 66

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

COOP vs. KRYS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Mr. Cooper Group Inc. (COOP) and Krystal Biotech, Inc. (KRYS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	COOP	KRYS	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	1.14	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.36	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	0.61	—

Correlation

The correlation between COOP and KRYS is 0.22, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

COOP vs. KRYS - Dividend Comparison

COOP's dividend yield for the trailing twelve months is around 0.95%, while KRYS has not paid dividends to shareholders.

	TTM	2025
COOP Mr. Cooper Group Inc.	0.95%	0.95%
KRYS Krystal Biotech, Inc.	0.00%	0.00%

Drawdowns

Drawdown Indicators

	COOP	KRYS	Difference
Max Drawdown Largest peak-to-trough decline	—	-53.42%	—
Max Drawdown (1Y) Largest decline over 1 year	—	-31.85%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-51.34%	—
Current Drawdown Current decline from peak	—	-11.31%	—
Average Drawdown Average peak-to-trough decline	—	-16.43%	—
Ulcer Index Depth and duration of drawdowns from previous peaks	—	14.61%	—

Volatility

Volatility by Period

	COOP	KRYS	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	9.78%	—
Volatility (6M) Calculated over the trailing 6-month period	—	25.71%	—
Volatility (1Y) Calculated over the trailing 1-year period	—	42.66%	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	—	76.66%	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	—	74.80%	—

Financials